Yearly Archives2016

ExeGi Pharma Recognizes World AIDS Day standard

ROCKVILLE, MD., Dec. 1, 2016– December 1st marks the observation of the 28th World AIDS Day, a day dedicated to the fight against HIV, those who have lost their lives to AIDS, and those currently living with HIV. ExeGi Pharma recognizes World AIDS Day and reaffirms its commitment to the research of Visbiome, a high potency multi-strain probiotic, in restoring the microbiome of people living with HIV. Visbiome is a medical food which is currently the subject of two ongoing, publically sponsored, clinical trials, in the United States and Canada, evaluating the safety, tolerability, and effect of Visbiome on the gut microbiome and immune activation markers in people living with HIV who are currently on suppressive antiretroviral therapy (ART). World ...

Continue Reading

ExeGi Pharma Announces Visbiome™ Probiotic Now Available in Canada standard

ExeGi Pharma Announces Visbiome™ Probiotic Now Available in Canada Widely-studied De Simone Formulation proven to help patients with gastrointestinal conditions manage their symptoms ROCKVILLE, Md., Sept. 8, 2016 /CNW/ -- ExeGi Pharma, LLC, announced today that Visbiome™, a high potency probiotic, is now available in Canada. Visbiome contains a proprietary blend of eight strains of live beneficial bacteria and is available in concentrations of 450 billion colony forming units (CFUs) bacteria per sachet. The innovative formulation in Visbiome (the "De Simone Formulation") was originally invented by Professor Claudio De Simone, MD, more than 20 years ago and has been subject to extensive research in 60 studies and more than 170 scientific publications. Visbiome is a probiotic that delivers probiotic bacteria in high ...

Continue Reading

This is a unique website which will require a more modern browser to work!

Please upgrade today!